Clinical case of relief of subepithelial corneal opacities after adenovirus keratoconjunctivitis with the use of biopolymer hydrogel
E. Yu. Ilyukhina,
L. Sh. Ramazanova,
R. Z. Shamratov,
O. A. Napylova,
M. B. Bagirov,
S. S. Ihsanov,
A. S. Rejepova https://doi.org/10.17021/2712-8164-2025-4-39-44
Abstract
Subepithelial corneal opacities are a common consequence of adenoviral and mixed-infection keratoconjunctivitis, occurring in 10 % of cases. They rarely undergo spontaneous resorption, persisting for life in most cases and often causing decreased vision and quality of life in patients. This paper examines clinical cases of treating subepithelial corneal opacities developed in the context of adenoviral ocular surface damage – keratoconjunctivitis, with corneal opacities resorption using a byopolymer hydrogel (SPHERO®oko, BIOMIR service JSC, Russia).
About the Authors
E. Yu. Ilyukhina
Astrakhan State Medical University
Russian Federation
Russian Federation
Ekaterina Yu. Ilyukhina, Assistant Professor of the Department
Astrakhan
L. Sh. Ramazanova
Astrakhan State Medical University
Russian Federation
Russian Federation
Liya Sh. Ramazanova, Dr. Sci. (Med.), Professor of the Department
Astrakhan
R. Z. Shamratov
Astrakhan State Medical University
Russian Federation
Russian Federation
Rakhim Z. Shamratov, Cand. Sci. (Med.), Assistant Professor of the Department
Astrakhan
O. A. Napylova
LLC Center of Modern Technologies
Russian Federation
Russian Federation
Olga A. Napylova, ophthalmologist
Astrakhan
M. B. Bagirov
LLC Center of Modern Technologies
Russian Federation
Russian Federation
Muhammed B. Bagirov, ophthalmologist
Astrakhan
S. S. Ihsanov
LLC Center of Modern Technologies
Russian Federation
Russian Federation
Samat S. Ihsanov, ophthalmologist
Astrakhan
A. S. Rejepova
Scientific and Clinical Center for Eye Diseases of the Myrat Garryev State Medical University of Turkmenistan
Turkmenistan
Turkmenistan
Altyn S. Rejepova, Chief Physician
Ashgabat
References
1. Labib B. A., Minhas B. K., Chigbu D. I. Treatment of adenoviral keratoconjunctivitis: challenges and solutions. Clinical ophthalmology. 2020; 14: 837–852. doi: 10.2147/OPTH.S207976. PMID: 32256043; PMCID: PMC7094151.
2. Jhanji V., Chan T. C., Li E. Y., Agarwal K., Vajpayee R. B. Adenoviral keratoconjunctivitis. Surv Ophthalmol. 2015 Sep-Oct; 60 (5): 435–443. doi: 10.1016/j.survophthal.2015.04.001. PMID: 26077630.
3. Muto T., Imaizumi S., Kamoi K. Viral conjunctivitis. Viruses. 2023; 15 (3): 676. doi: 10.3390/v15030676. PMID: 36992385; PMCID: PMC10057170.
4. Amoaku W. K., McCarty C. A.: Infectious diseases of the cornea. Survey of Ophthalmology. 2000; 45 (2): 121–136.
5. Infectious diseases: national guidelines. Ed. by N. D. Yushchuk, Yu. Ya. Vengerov. 2nd ed., revised and enlarged. Moscow: GEOTAR Media; 2019.
6. Jhanji V., Chan T. C., Li E. Y., Agarwal K., Vajpayee R. B. Adenoviral keratoconjunctivitis. Surv Ophthalmol. 2015; 60 (5): 435–443. https://doi.org/10.1016/j.survophthal.2015.04.001.
7. Chintakuntlawar A. V., Chodosh J. Cellular and tissue architecture of conjunctival membranes in epidemic keratoconjunctivitis. Ocul Immunol Inflamm. 2010; 18 (5): 341–345. doi: 10.3109/09273948.2010.498658.
8. Ophthalmology. National Guidelines. Ed. by S. E. Avetisov, E. A. Egorova, L. K. Moshetova, V. V. Neroev, H. P. Takhchidi. Moscow: GEOTAR-Media; 2019: 752 p.
9. Maychuk D. Yu., Vasileva O. A., Russu L. I., Mezentseva M. V. Clinical and immunological comparisons of therapeutic regimens for corneal infiltrates secondary to adenoviral keratoconjunctivitis. Bulletin of Ophthalmology. 2015; 131 (4): 49–55. doi: 10.17116/oftalma2015131449-55 (In Russ.).
10. Instructions for use of the medical device SPHERO®oko. JSC “BIOMIR service”. URL: https://files.biomir.biz/ophthalmology/%D0%A1%D0%A4%D0%9E%D0%BA%D0%BE_%D0%B8%D0%BD%D1%81%D1%82%D1%80%D1%83%D0%BA%D1%86%D0%B8%D1%8F.pdf (In Russ.).
Review
For citations:
Ilyukhina E.Yu., Ramazanova L.Sh., Shamratov R.Z., Napylova O.A., Bagirov M.B., Ihsanov S.S., Rejepova A.S. Clinical case of relief of subepithelial corneal opacities after adenovirus keratoconjunctivitis with the use of biopolymer hydrogel. Title. 2025;6(4):39-44. (In Russ.) https://doi.org/10.17021/2712-8164-2025-4-39-44
Views:
33
Email this article 